Nav: Home

Survival Current Events | Page 11

Survival Current Events, Survival News Articles.
Sort By: Most Viewed | Most Recent
Page 11 of 25 | 1000 Results
Hospital choice could determine survival after a heart attack
Where you go for heart attack care may matter for both your short- and long-term risk of death, according to a new study by Yale School of Medicine researchers appearing in the New England Journal of Medicine. (2016-10-10)
Study says VeriStrat predicts response but not survival benefit from erlotinib
A study, published in the November 2012 issue of the International Association for the Study of Lung Cancer's Journal of Thoracic Oncology, showed the plasma test VeriStrat can predict response but not survival benefit from erlotinib. (2012-10-15)
Hormone levels linked to survival of deer calves, study suggests
Levels of a key hormone in the blood may be important for the survival prospects of newborn animals, a study of wild deer suggests. (2014-03-27)
African-Americans more likely to die of colon cancer
African-Americans with colon cancer are more than 50 percent more likely to die of their cancer within five and ten years after surgery than Caucasians. (2004-05-24)
Benefit of surgery for ductal carcinoma in-situ investigated
In a study published in JAMA Surgery on June 3, researchers from Brigham and Women's Hospital report that breast surgery performed at or shortly after a diagnosis of low-grade ductal carcinoma in-situ (DCIS) did not significantly change patients' survival rate. (2015-06-03)
Breast reconstruction with implants after mastectomy doesn't hurt survival chances
Breast implants after mastectomy to treat breast cancer do not reduce the long-term survival of patients, reveals the first study on the long-term effects of breast implants, published today in Breast Cancer Research. (2004-12-22)
Addition of chemotherapy to radiotherapy continues to increase survival in patients with brain tumors for up to 5 years
Giving patients with glioblastoma -- the most common and aggressive form of primary brain tumor -- the chemotherapy drug temozolomide in combination with radiotherapy increases their survival compared with those receiving radiotherapy alone and this improvement persists for up to 5 years, according to the final results of the EORTC-NCIC trial, published online first and in the May edition of the Lancet Oncology. (2009-03-08)
Novel biomarker for prediction of survival in colorectal carcinomas revealed
Levels of a protein called thymidylate synthase within two separate compartments of a tumor cell -- the nucleus and the cytoplasm -- may be critical markers predicting survival in colorectal cancer, according to a study at Yale University School of Medicine. (2006-09-13)
Indigenous cancer patients in Australia fare worse than their non-indigenous counterparts
Indigenous cancer patients in Australia have a 30 percent higher chance of death from cancer than their non-Indigenous counterparts, according to a paper in this week's issue of The Lancet. (2006-06-01)
Tumor size predicts survival in patients with lung cancer
A new study in the November issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP) shows that patients with lung tumors less than 2 cm in size had a higher 5-year survival rate than patients with tumors 2 to 3 cm in size. (2003-11-10)
Elderly leukemia patients benefit from intensive treatment
Contrary to popular belief, patients over the age of 75 with acute myelogenous leukemia (AML) do just as well as younger patients with similar chemotherapy regimens. (2004-06-07)
Doxorubicin alone or with ifosfamide for treating soft tissue sarcoma?
An EORTC study published in The Lancet Oncology does not support administration of intensified doxorubicin and ifosfamide for palliation of advanced soft tissue sarcoma, unless the objective is to shrink the tumor. (2014-03-25)
Quality of life: most important predictor of survival for advanced NSCLC patients
Healthcare providers have observed it for years -- patients who appear to have a better quality of life while battling their cancer live longer. (2007-10-30)
Breast conserving treatment with radiotherapy reduces risk of local recurrence
Results of EORTC trial 10853 appearing in the Journal of Clinical Oncology show that breast conserving treatment combined with radiotherapy reduces the risk of local recurrence in women with ductal carcinoma in situ. (2013-09-18)
Mayo Clinic finds aggressive surgery best option for advanced-stage ovarian cancer patients
Mayo Clinic Cancer Center researchers report aggressive surgical removal of as much cancer as possible throughout the abdomen in ovarian cancer patients is the best option for most women. (2006-01-09)
Predicting survival after liver transplantation
Patients awaiting liver transplantation who also suffer from other medical problems may face poorer survival after transplantation. (2007-11-05)
Social factors not genetics drive racial disparities in colorectal cancer survival
Correcting social, economic and health-care inequalities may have the most significant impact in reducing survival differences in colorectal cancer between African-Americans and Caucasians, according to a new study. (2007-04-23)
OHSU Cancer Institute physicians validate reclassification of breast cancer stages
Breast cancer is diagnosed as having progressed to any of four stages, Stage IV being the most advanced. (2006-06-05)
Liver cancer patients with high serum levels of hepatitis B virus face poorer outcomes
Researchers report their findings from the first-ever study examining the prognostic value of serum HBV DNA levels for patients with liver cancer undergoing chemotherapy. (2007-06-01)
Preterm births higher among deprived mothers, despite equal care
Despite improvements in obstetric care services, women from deprived areas are still more likely to give birth to a very preterm baby compared with mothers from more affluent areas, finds a study published on today. (2009-12-01)
Specific lymph node radiotherapy is well tolerated after surgery in early breast cancer patients
In patients with early breast cancer, giving radiotherapy to the lymph nodes located behind the breast bone and above the collar bone is well-tolerated, after mastectomy or breast conserving surgery, says a large international study, at the European Breast Cancer Conference. (2010-03-26)
Extracorporeal life support doubles chances of survival in cardiac arrest patients
Extracorporeal life support combined with conventional cardiopulmonary resuscitation roughly doubles survival in adult hospital patients compared with CPR alone. (2008-07-06)
20 years of data shows treatment technique improvement for advanced abdominal cancer
Wake Forest Baptist has the largest reported, single-center experience with cytoreductive surgery and HIPEC and analysis of 20 years' worth of patient data shows that outcomes have clearly improved for patients undergoing this treatment technique. (2014-04-17)
Electric fields therapy improves survival for patients with brain tumor
Patients with glioblastoma, an aggressive brain tumor who received a type of electric fields therapy that interferes with cell division had better overall survival and survival without progression of the tumor compared to standard chemotherapy. (2017-12-19)
New type of drug shows promise in attacking melanoma in an innovative way
An experimental drug that attacks cancer in an entirely new way has shown promise in treating advanced melanoma, delaying progression of the disease and prolonging the lives of patients. (2007-09-26)
Thalidomide improves survival of elderly with multiple myeloma when added to chemotherapy regimen
The addition of thalidomide to the standard combination chemotherapy treatment of melphalan plus prednisone for elderly patients with multiple myeloma significantly improves survival. (2007-10-04)
Reprogramming stem cells to a more basic form results in more effective transplant, study shows
Chinese stem cell scientists have published new research that improves the survival and effectiveness of transplanted stem cells. (2011-11-03)
Irradiation of regional nodes in stage I - III breast cancer patients affects overall survival
At a median follow-up of 10.9 years, an EORTC study has shown that irradiation of regional nodes in patients with stage I, II, or III breast cancer has a marginal effect on overall survival, the primary endpoint (at 10 years, overall survival was 82.3 percent for regional irradiation versus 80.7 percent for no regional irradiation). (2015-08-03)
Premature infant survival and health outcomes improve over 20 years, new study shows
A study of extremely preterm infants born at US academic medical centers over the last 20 years found changes in maternal and infant care practices, resulting in modest increases in survival and reductions in several neonatal complications. (2015-09-08)
Intrauterine surgery can improve the prognosis for the fetus
Fetuses with congenital malformations can be helped by surgical intervention while still in the womb. (2012-10-09)
Young patients more likely to die in countries where health care is funded by private insurance
Countries that have national health services easily accessible to people of all ages are more likely to have better survival rates for their teenagers and young adults (TYAs) with cancer, than are countries where individuals have to pay for their own medical insurance, according to new research presented at Teenage Cancer Trust's conference in London. (2006-03-31)
Second cancers deadlier in young patients
Second cancers in children and adolescents and young adults (AYA) are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall, a new study by UC Davis researchers has found. (2017-04-20)
Heart transplants benefit only the sickest patients
Heart transplantation improves survival only in patients with the worst heart failure and therefore at the highest risk of death while on the waiting list, according to a study in this week's BMJ. (2000-08-31)
Underutilized treatment for advanced ovarian cancer found to significantly improve survival
According to a study published in the January 5 issue of the New England Journal of Medicine, women with Stage III ovarian cancer given a combination of intravenous (IV) and intra-abdominal chemotherapy, following the successful surgical removal of tumors, experienced a median survival time 16 months longer than women who received IV chemotherapy alone. (2006-01-04)
Survival in metastatic breast cancer directly linked to circulating tumor cells
A new study of metastatic breast cancer shows that the number of circulating tumor cells patients have in their blood directly correlates with the length of their survival. (2010-05-06)
Reforestation of burnt earth: Use truffles
Researchers at the Botany Department of the University of Navarra, Ana María de Miguel y Miriam de Román, have undertaken a study on the use of mycorrhizzae-introduced plants (colonised with the Tuber melanosporum fungus or black Perigord truffle), on surface land areas affected by fires. (2005-09-12)
Advances in liver surgery enable the prospect of curative treatment for more patients
Patients with liver metastases from colorectal cancer are increasingly benefiting from curative surgical treatment. (2009-06-12)
Autophagy: A double-edged sword for neuronal survival after cerebral ischemia
A research team from the Sixth People's Hospital Affliated to Shanghai Jiao Tong University, Shanghai, China and Zhoupu Hospital, Pudong New District, Shanghai, China, summarizes the potential role and possible signaling pathway of autophagy in neuronal survival after cerebral ischemia and proposes that autophagy has dual effects. (2014-07-25)
Better sleep predicts longer survival time for women with advanced breast cancer
A new study reports that sleep efficiency, a ratio of time asleep to time spent in bed, is predictive of survival time for women with advanced breast cancer. (2014-05-02)
Adding cediranib to chemo improves progression-free survival for meta or recurrent cervical cancer
For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to standard chemotherapy improves tumour shrinkage and adds a modest improvement in progression-free survival, researchers report at the ESMO 2014 Congress in Madrid. (2014-09-28)
Page 11 of 25 | 1000 Results
   First   Previous   Next      Last   

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

The Big Five
What are the five biggest global challenges we face right now — and what can we do about them? This hour, TED speakers explore some radical solutions to these enduring problems. Guests include geoengineer Tim Kruger, president of the International Rescue Committee David Miliband, political scientist Ian Bremmer, global data analyst Sarah Menker, and historian Rutger Bregman.
Now Playing: Science for the People

#456 Inside a Conservation NGO
This week we take a close look at conservation NGOS: what they do, how they work, and - most importantly - why we need them. We'll be speaking with Shyla Raghav, the Climate Change Lead at Conservation International, about using strategy and policy to tackle climate change. Then we'll speak with Rebecca Shaw, Lead Scientist at the World Wildlife Fund, about how and why you should get involved with conservation initiatives.